Yonghong Zhou Selected Research

Yonghong Zhou Research Topics

Disease

9	Infections 11/2022 - 02/2008
6	Neoplasms (Cancer) 01/2024 - 03/2010
4	Osteosarcoma (Osteogenic Sarcoma) 08/2020 - 12/2016
3	Hemorrhage 11/2022 - 12/2015
3	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2022 - 10/2019
3	Tetraploidy 11/2021 - 10/2011
3	Necrosis 08/2020 - 10/2010
3	Malaria 12/2016 - 12/2008
3	Cerebral Malaria 10/2010 - 12/2008
3	Hepatocellular Carcinoma (Hepatoma) 11/2008 - 05/2005
2	Dwarfism 01/2021 - 01/2016
2	Wounds and Injuries (Trauma) 08/2017 - 12/2015
2	Visceral Leishmaniasis (Kala Azar) 03/2010 - 09/2008
2	Communicable Diseases (Infectious Diseases) 03/2010 - 09/2008
1	Squamous Cell Carcinoma of Head and Neck 01/2024
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2023
1	Dehydration (Water Stress) 04/2023
1	Esophageal Achalasia (Megaesophagus) 11/2022
1	Esophageal and Gastric Varices (Esophageal Varices) 03/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022
1	Liver Neoplasms (Liver Cancer) 03/2022
1	Polyploidy 11/2021
1	Weight Loss (Weight Reduction) 09/2020
1	Herpangina 01/2020
1	Adenocarcinoma of Lung 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Pleural Effusion (Pleural Effusions) 01/2019
1	Carcinogenesis 10/2018
1	Neoplasm Metastasis (Metastasis) 10/2018

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2005
3	RNA (Ribonucleic Acid)IBA 10/2018 - 12/2016
2	Neutralizing AntibodiesIBA 11/2022 - 01/2022
2	AntibodiesIBA 11/2022 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 03/2022 - 01/2019
2	NitrogenIBA 01/2021 - 08/2020
2	GibberellinsIBA 01/2019 - 01/2016
2	Messenger RNA (mRNA)IBA 10/2018 - 06/2017
2	MicroRNAs (MicroRNA)IBA 10/2018 - 06/2017
2	CytokininsIBA 08/2017 - 01/2016
2	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2010 - 07/2010
2	CytokinesIBA 12/2008 - 02/2008
1	Air Pollutants (Pollutants, Air)IBA 10/2023
1	terpinIBA 04/2023
1	BariumIBA 11/2022
1	ErbB Receptors (EGF Receptor)IBA 03/2022
1	osimertinibIBA 03/2022
1	BilirubinIBA 03/2022
1	Amino Acids FDA Link 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 12/2020
1	hydroxyethyl methacrylate (HEMA)IBA 09/2020
1	E 25 (E-25)IBA 09/2020
1	Urea (Carbamide)FDA LinkGeneric 08/2020
1	taribavirin (viramidine)IBA 08/2020
1	Alkaline PhosphataseIBA 08/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2020
1	AlbuminsIBA 08/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2020
1	oxidized low density lipoproteinIBA 08/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 08/2020
1	EnzymesIBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	Combined VaccinesIBA 10/2019
1	VaccinesIBA 10/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	EstersIBA 01/2019
1	AcidsIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	13-chlorine-3,15-dioxy-gibberellic acid methyl esterIBA 01/2019
1	betaglycan (TGFBR3)IBA 10/2018
1	Long Noncoding RNAIBA 10/2018
1	Competitive Endogenous RNAIBA 10/2018
1	CarcinogensIBA 10/2018
1	SaltsIBA 01/2018
1	benzylaminopurineIBA 08/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	ChemokinesIBA 12/2016
1	Arachidonic Acid (Vitamin F)IBA 12/2016
1	PolyaminesIBA 01/2016
1	HomocysteineIBA 01/2016
1	Abscisic AcidIBA 01/2016
1	LigninIBA 01/2016
1	FlavonoidsIBA 01/2016
1	CelluloseIBA 01/2016
1	Methionine (L-Methionine)FDA Link 01/2016
1	HydrolasesIBA 01/2016
1	Indoleacetic Acids (Auxin)IBA 01/2016
1	brassinolideIBA 01/2016
1	Uridine Triphosphate (UTP)IBA 12/2015
1	batimastat (BB 94)IBA 12/2015
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2015

Therapy/Procedure

2	Immunotherapy 01/2024 - 03/2010
2	Therapeutics 01/2024 - 02/2008
1	Myotomy 11/2022
1	Ligation 03/2022
1	Neoadjuvant Therapy 08/2020
1	Drug Therapy (Chemotherapy) 08/2020
1	Aftercare (After-Treatment) 01/2019